UTUnited Therapeutics UTHR · NASDAQ
$593.54 +1.20% (+$7.06)
- Market cap
- $25.5B
- Enterprise value
- $23.7B
- P/E
- 19.4x
- Forward P/E
- 20.3x
- PEG
- 1.6x
- P/S
- 8.1x
- P/FCF
- 23.3x
- EV/EBITDA
- 14.3x
- ROIC
- 17.7%
- Bruto marža
- 86.1%
- Neto marža
- 41.6%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -1.1x
- Beta
- 0.56
- Free float
- 91.4%
O podjetju
United Therapeutics Corporation is an American biotechnology company headquartered in Silver Spring, Maryland. The company focuses on the development and manufacturing of drugs for the treatment of pulmonary arterial hypertension and other pulmonary and vascular-related diseases. Their main drugs include therapies for the treatment of pulmonary arterial hypertension and carcinoid syndrome. United Therapeutics is also involved in research and development of new drug formulations in the field of regenerative medicine and organ transplantation. The company is known for its innovative approach to treating pulmonary diseases and comprehensive research in the field of biotechnology. Shares of United Therapeutics Corporation are publicly traded on the NASDAQ stock exchange.
Sector
Healthcare
Industry
Biotechnology
CEO
Martine A. Rothblatt
Employees
1,400
Headquarters
Silver Spring
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
- Kaj govori v prid: Dobiček na delnico je v zadnjih 3 letih rasel za 23 % letno.
- Na kaj bodite pozorni: Napovedi dobička ni dosegla 4-krat v zadnjih 8 četrtletjih.
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
- Kaj govori v prid: Od vsakih 100 USD prihodkov ostane 42 USD čistega dobička.
- Kaj govori v prid: Na vsakih 100 USD vloženega kapitala zasluži 18 USD letno.
Finančno zdravje
Ali zmore svoj dolg?
- Kaj govori v prid: Nima dolga in ima $1,80B denarja.
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke